This Week’s Biopharma News: Argentina’s WHO Exit and Sanofi Acquisition of Blueprint Medicines
By Rob Coker
June 6, 2025
Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
4 min read
False
Advertisement
Business Practice
AI or Tradition: The Great Pharma Sales Dilemma
June 3, 2025
Pharma sales teams are under pressure, but traditional training models aren’t keeping up. Can AI help?
3 min read
This Week’s Biopharma News: Pfizer and Astellas Drug Improves Cancer Survival
By Rob Coker
May 30, 2025
Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.
4 min read
Behind the Scenes of a GMP Win
May 29, 2025
We ask a company about lessons learned from the GMP certification process.
4 min read
The New Age of Global, Political, and Regulatory Challenges
May 28, 2025
A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in – and unique to – the pharmaceutical industry, from supply chains to tariffs, and more.
7 min read
What Trump’s Latest Moves Mean for the Industry
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
This Week’s Industry News: Changes at the top of Novo Nordisk
May 22, 2025
Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.
3 min read
Building Better Biologics – While Being Sustainable
May 22, 2025
Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference
7 min read
The Challenges and Successes of A Biotech Startup
May 21, 2025
Discussing the challenges facing small rare disease-focussed biotechs, what they offer in terms of speed and agility, and the successes of advancing treatments.
3 min read
Denmark and Sweden Invite Misplaced US Scientists to the EU
By Rob Coker
May 8, 2025
Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.
2 min read
